                         SEQUENCE LISTING

<110>  The United States of America, as represented by the 
       Secretary, Department of Health and Human Services
       Aleta Biotherapeutics, Inc.
 
<120>  TARGETED CANCER THERAPY

<130>  A0915.70013WO00

<140>  Not Yet Assigned
<141>  2016-10-28

<150>  US 62/249,013
<151>  2015-10-30

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Polynucleotide

<400>  1
agctgtatgt gtgggc                                                       16


<210>  2
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Polynucleotide

<400>  2
gctccacact ttggctgt                                                     18


<210>  3
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Polynucleotide

<400>  3
cttcaaagtg acgcctcc                                                     18


<210>  4
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Polynucleotide

<400>  4
tctatgagaa cgactcc                                                      17


